Relationships of iduronic acid-2-sulfatase with metastasis and prognosis of colorectal cancer

Zeyu YANG; Xiaoli HE; Tao TANG; Di WANG; Xuemei LIAO; Shicang YU

doi:10.16016/j.1000-5404.201903189

您当前的位置：

首页 >

文章列表页 >

Relationships of iduronic acid-2-sulfatase with metastasis and prognosis of colorectal cancer

Basic Medicine | 更新时间：2026-01-09

- Relationships of iduronic acid-2-sulfatase with metastasis and prognosis of colorectal cancer
- Journal of Third Military Medical University Vol. 41, Issue 17, Pages: 1635-1641(2019)
- 作者机构：
  
  1.400038 重庆，陆军军医大学(第三军医大学)第一附属医院:全军临床病理学研究所，西南癌症中心
  2.400038 重庆，陆军军医大学(第三军医大学)第一附属医院:干细胞与再生医学科
- 作者简介：
- 基金信息：
  
  the General Program of National Natural Science Foundation of China(81572880)
- DOI：10.16016/j.1000-5404.201903189
  CLC： R345;R730.7;R735.3
- Received：22 March 2019，
  
  Revised：2019-06-14，
  
  Published：15 September 2019
- 稿件说明：
移动端阅览
Zeyu YANG, Xiaoli HE, Tao TANG, et al. Relationships of iduronic acid-2-sulfatase with metastasis and prognosis of colorectal cancer[J]. Journal of Third Military Medical University, 2019, 41(17): 1635-1641.
DOI：

Zeyu YANG, Xiaoli HE, Tao TANG, et al. Relationships of iduronic acid-2-sulfatase with metastasis and prognosis of colorectal cancer[J]. Journal of Third Military Medical University, 2019, 41(17): 1635-1641. DOI： 10.16016/j.1000-5404.201903189.

摘要

目的

寻找与结直肠癌转移相关并具有预后预测意义的溶酶体分子。

方法

获取TCGA数据库结直肠癌数据集(Colon Adenocarcinoma TCGA-632)结直肠癌临床样本信息和基因转录组测序表达矩阵；通过基于LASSO(least absolute shrinkage and selection operator)算法的Logistic回归筛选与远处转移相关的溶酶体基因；进一步利用基于LASSO算法的COX回归模型，筛选与结直肠癌患者预后相关的基因，并选择回归系数最大的艾杜糖醛酸-2-硫酸酯酶(iduronic acid-2-sulfatase，IDS)进行研究；收集本院2007-2008年50例结直肠癌患者肿瘤组织标本进行免疫组织化学染色，分析组织中IDS表达量与转移及预后的关系。

结果

TCGA数据库分析显示:发生淋巴结转移的结直肠癌患者IDS mRNA相对表达量高于无淋巴结转移的患者(N

1-2

: -0.103±0.073

0.303±0.123，

=0.003)；发生远处转移的结直肠癌患者IDS mRNA相对表达量高于无远处转移的患者(M

: 0.017±0.071

0.636±0.296，

=0.003)；IDS高表达患者的预后较低表达患者不良(总体生存期:

=0.008；无病生存期:

=0.007)；COX回归分析显示:IDS mRNA高表达是结直肠癌患者预后不良的独立预测因素(

=0.014，风险系数为2.651，95%

:1.217~5.775)；50例结直肠癌组织免疫组化分析显示:发生淋巴结转移的结直肠癌患者IDS mRNA相对表达量高于无淋巴结转移的患者(N

1-3

: 27.324±0.698

40.674±3.528，

=3.0×10

-5

)；发生远处转移的结直肠癌患者IDS mRNA相对表达量高于无远处转移的患者(M

: 27.941±0.952

39.320±3.467，

=1.2×10

-5

)；IDS高表达患者预后不良(

=7.2×10

-5

)；COX回归分析显示:IDS高表达是预后不良的独立预测因素(

=0.008，风险系数为5.847，95%

:1.585~21.568)。

结论

IDS高表达的结直肠癌患者转移发生率高、预后差，IDS可作为结直肠癌患者独立预后预测因子。

Abstract

Objective

To select lysosomal molecules related to metastasis and prognosis of colorectal cancer.

Methods

The clinical sample information and gene transcriptome sequencing expression matrix of colorectal cancer TCGA database (Colon Adenocarcinoma TCGA-632) were obtained. The lysosomal genes associated with distant metastasis were screened by least absolute shrinkage and selection operator (LASSO)-based logistic regression. Further the LASSO-based COX regression model was employed to screen the genes closely related to prognosis of colorectal cancer patients. Among those genes

the iduronic acid-2-sulfatase (IDS) was selected because of its largest regression coefficient. Then

50 paraffin embedded colorectal cancer tissues harvested in our hospital from 2007 to 2008 were used for IDS immunohistochemistry staining. The relationships of IDS expression level in the tissues with metastasis and prognosis of colorectal cancer were analyzed.

Results

The results of TCGA database analysis showed that the relative mRNA expression level of IDS was significantly higher in the colorectal cancer patients with lymph node metastasis than those without (N

1-2

: -0.103±0.073

0.303±0.123

=0.003)

and was much higher in those with distant metastasis than those without (M

: 0.017±0.071

0.636±0.296

=0.003); and the patients with high expression of IDS had poor prognosis (overall survival:

=0.008; disease-free survival:

=0.007). COX regression analysis indicated that the mRNA expression of IDS was an independent predictors of colorectal cancer prognosis (

=0.014

Hazard ratio=2.651

95%

: 1.217~5.775). The results of immunohistochemical analysis for the 50 cases showed that the expression of IDS was higher in colorectal cancer patients with lymph node metastasis than those without (N

1-3

: 27.324±0.698

40.674±3.528

=3.0×10

-5

)

and was higher in those with distant metastasis than those without (M

: 27.941±0.952

39.320±3.467

=1.2×10

-5

)

and the patients with high IDS expression suggested poor prognosis (

=7.2×10

-5

). COX regression analysis also suggested that IDS expression was an independ

ent predictor of colorectal cancer prognosis (

=0.008

Hazard ratio=5.847

95%

: 1.585~21.568).

Conclusion

The colorectal cancer patients with high expression of IDS is associated with high risk of metastasis and poor prognosis. The molecule could be regarded as an independent predictor of colorectal cancer patients.

关键词

Keywords

references

BRAY F, FERLAY J, SOERJOMATARAM I, et al . Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J ] . CA Cancer J Clin, 2018, 68(6): 394-424. DOI:10.3322/caac.21492.

YU W Y, JIANG J F, XIE L L, et al . Mortality trends in colorectal cancer in China during 2000-2015: A joinpoint regression and age-period-cohort analysis[J ] . Prev Chronic Dis, 2018, 15: E156. DOI:10.5888/pcd15.180329.

DAVIDSON S M, VANDER HEIDEN M G. Critical functions of the lysosome in cancer biology[J]. Annu Rev Pharmacol Toxicol, 2017, 57: 481-507. DOI:10.1146/annurev-pharmtox-010715-103101.

TOWERS C G, THORBURN A. Targeting the lysosome for cancer therapy[J]. Cancer Discov, 2017, 7(11): 1218-1220. DOI:10.1158/2159-8290.CD-17-0996.

ZHOU W H, GONG L, WU Q C, et al . PHF8 upregulation contributes to autophagic degradation of E-cadherin, epithelial- mesenchymal transition and metastasis in hepatocellular carcinoma[J ] . J Exp Clin Cancer Res, 2018, 37(1): 215. DOI:10.1186/s13046-018-0890-4.

LIU H, MA Y, HE H W, et al . SPHK1 (sphingosine kinase 1) induces epithelial-mesenchymal transition by promoting the autophagy-linked lysosomal degradation of CDH1/E-cadherin in hepatoma cells[J ] . Autophagy, 2017, 13(5): 900-913. DOI:10.1080/15548627.2017.1291479.

ZHAO T, DING X C, YAN C, et al . Endothelial Rab7 GTPase mediates tumor growth and metastasis in lysosomal acid lipase-deficient mice[J ] . J Biol Chem, 2017, 292(47): 19198-19208. DOI:10.1074/jbc.M116.773093.

KUNDU S T, GRZESKOWIAK C L, FRADETTE J J, et al . TMEM106B drives lung cancer metastasis by inducing TFEB-dependent lysosome synthesis and secretion of cathepsins[J ] . Nat Commun, 2018, 9(1): 2731. DOI:10.1038/s41467-018-05013-x.

KIM S M, KIM Y, JEONG K, et al . Logistic LASSO regression for the diagnosis of breast cancer using clinical demographic data and the BI-RADS lexicon for ultrasonography[J ] . Ultrasonography, 2018, 37(1): 36-42. DOI:10.14366/usg.16045.

HOLMES R S. Comparative studies of vertebrate iduronate 2-sulfatase (IDS) genes and proteins: evolution of A mammalian X-linked gene[J]. 3 Biotech, 2017, 7(1): 22. DOI:10.1007/s13205-016-0595-3.

SMITH C M, FINGER J H, HAYAMIZU T F, et al . The mouse gene expression database (GXD): 2014 update[J ] . Nucleic Acids Res, 2014, 42(Database issue): D818-D824. DOI:10.1093/nar/gkt954.

DA SILVA E M, STRUFALDI M W, ANDRIOLO R B, et al . Enzyme replacement therapy with idursulfase for mucopolysaccharidosis type Ⅱ (Hunter syndrome)[J ] . Cochrane Database Syst Rev, 2016, 2: CD008185. DOI:10.1002/14651858.CD008185.pub4.

MEDEIROS M G, FERREIRA T M, LEITE E L, et al . New pathway of heparan sulphate degradation. Iduronate sulphatase and N-sulphoglucosamine 6-sulphatase act on the polymer chain prior to depolymerisation by a N-sulpho-glucosaminidase and glycuronidases in the mollusc Tagelus gibbus[J ] . Comp Biochem Phys B, 1998, 119(3): 539-547.

PASQUALINI J R. Role, control and expression of estrone sulfatase and 17 beta-hydroxysteroid dehydrogenase activities in human breast cancer[J]. Zentralbl Gynakol, 1997, 119(Suppl 2): 48-53.

AHMED S, OWEN C P, JAMES K, et al . Review of estrone sulfatase and its inhibitors: An important new target against hormone dependent breast cancer[J ] . Curr Med Chem, 2002, 9(2): 263-273.

NAKAMURA Y, SUZUKI T, FUKUDA T, et al . Steroid sulfatase and estrogen sulfotransferase in human prostate cancer[J ] . Prostate, 2006, 66(9): 1005-1012. DOI:10.1002/pros.20426.

CHURA J C, BLOMQUIST C H, RYU H S, et al . Estrone sulfatase activity in patients with advanced ovarian cancer[J ] . Gynecol Oncol, 2009, 112(1): 205-209. DOI:10.1016/j.ygyno.2008.08.037.

SHAH R, SINGH J, SINGH D, et al . Sulfatase inhibitors for recidivist breast cancer treatment: A chemical review[J ] . Eur J Med Chem, 2016, 114: 170-190. DOI:10.1016/j.ejmech.2016.02.054.

PUROHIT A, REED M J, MORRIS N C, et al . Regulation and inhibition of steroid sulfatase activity in breast cancer[J ] . Ann N Y Acad Sci, 1996, 784: 40-49.

WADE A N, ENGLER J R, TRAN V M, et al . Measuring sulfatase expression and invasion in glioblastoma[J ] . Methods Mol Biol, 2015, 1229: 507-516. DOI:10.1007/978-1-4939-1714-3_39.

PRINZ R D, WILLIS C M, VILORIA-PETIT A, et al . Elimination of breast tumor-associated chondroitin sulfate promotes metastasis[J ] . Genet Mol Res, 2011, 10(4): 3901-3913. DOI:10.4238/2011.December.8.9.

WILLIS C M, KLVPPEL M. Chondroitin sulfate-E is a negative regulator of a pro-tumorigenic Wnt/beta-catenin-Collagen 1 axis in breast cancer cells[J]. PLoS ONE, 2014, 9(8): e103966. DOI:10.1371/journal.pone.0103966.

TADEO I, GAMERO-SANDEMETRIO E, BERBEGALL A P, et al . 1p36 deletion results in a decrease in glycosaminoglycans which is associated with aggressiveness in neuroblastic tumors[J ] . Histol Histopathol, 2018, 33(5): 487-495. DOI:10.14670/HH-11-947.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Expression and clinical significance of extracellular matrix protein 1 in colorectal cancer

Proline-rich protein 11 is highly expressed in colorectal cancer to promote cancer cell invasion and metastasis

MiR-543/SNTB1 axis modulates immune microenvironment in colorectal cancer

Efficacy and safety of immunotherapy combined with targeted therapy and chemotherapy in third-line treatment of microsatellite stable metastatic colorectal cancer

Preparation of nanosized hypoxia-inducible factor 1α inhibitor and its application in reversing chemoresistance in colorectal cancer cells

Related Author

Sirui LONG

Debing XIANG

Yi SHEN

Guiyin SUN

Yao TANG

Jie WANG

Guiyin SUN

ZHANG Min

Related Institution

Department of Oncology, Jiangjin District Central Hospital

Department of Oncology, the Affiliated Hospital of Southwest Medical University

Department of Oncology, Affiliated Hospital of Southwest Medical University

School of Medicine, Xinyang Hospital of Traditional Chinese Medicine

School of Pharmaceutical Sciences， Xinyang Vocational and Technical College， Xinyang， Henan, Xinyang Hospital of Traditional Chinese Medicine

⁰